Sign in
4

Changes in Ownership

ELITE PHARMACEUTICALS INC /NV/ Filed Acc 0001053369-17-000004

Director acquired 133,019 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Ward Carter Julian Director 2017-02-23 Grant or award +133,019 $0.23 $29,996 1,885,304 D
Loading xslF345X03/primary_doc.xml…